BriaCell Financial Statements From 2010 to 2025

BCTXZ Stock   0.30  0.04  15.38%   
BriaCell Therapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing BriaCell Therapeutics' valuation are provided below:
We have found one hundred twenty available fundamental signals for BriaCell Therapeutics Corp, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of BriaCell Therapeutics Corp prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 4.1 M in 2025. Enterprise Value is likely to rise to about (5.9 M) in 2025
Check BriaCell Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BriaCell Therapeutics' main balance sheet or income statement drivers, such as Other Operating Expenses of 40.2 M, Total Operating Expenses of 28.6 M or Total Other Income Expense Net of 34.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.16. BriaCell financial statements analysis is a perfect complement when working with BriaCell Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with BriaCell Stock
Check out the analysis of BriaCell Therapeutics Correlation against competitors.

BriaCell Therapeutics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets10.9 M21.6 M12.1 M
Slightly volatile
Total Current Liabilities4.2 MM1.7 M
Slightly volatile
Accounts Payable8.7 M8.2 M1.7 M
Slightly volatile
Cash7.9 M10.5 MM
Slightly volatile
Non Current Assets Total1.2 M1.7 M1.4 M
Slightly volatile
Cash And Short Term Investments18.8 M17.9 M10.4 M
Slightly volatile
Liabilities And Stockholders Equity10.9 M21.6 M12.1 M
Slightly volatile
Other Stockholder Equity135.7 M129.2 M19.1 M
Slightly volatile
Total Liabilities6.3 M4.3 M7.6 M
Slightly volatile
Total Current Assets20.9 M19.9 M11.3 M
Slightly volatile
Net Receivables1.7 M1.6 M344.1 K
Slightly volatile
Other Current Liabilities4.2 MM980 K
Slightly volatile
Short Term Investments8.9 M8.5 M4.2 M
Slightly volatile
Common Stock87.1 M83 M32.1 M
Slightly volatile
Intangible Assets188.7 K184.5 K129.7 K
Slightly volatile
Current Deferred Revenue405.5 K456.2 K497.4 K
Slightly volatile
Short and Long Term Debt Total22.2 K23.4 K605.4 K
Slightly volatile
Short Term Debt213.6 K224.8 K685.9 K
Slightly volatile
Non Current Liabilities Total320.8 K337.7 K5.8 M
Slightly volatile
Long Term Debt20.8 K23.4 K25.5 K
Slightly volatile
Common Stock Shares Outstanding1.2 M1.4 M1.1 M
Slightly volatile
Long Term Investments505.3 K481.3 K87.8 K
Slightly volatile
Capital Stock72.1 M83 M60.3 M
Slightly volatile

BriaCell Therapeutics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses40.2 M38.3 M11.1 M
Slightly volatile
Total Operating Expenses28.6 M27.2 M9.7 M
Slightly volatile
Depreciation And Amortization112 K106.6 K24.8 K
Slightly volatile
Selling General Administrative6.2 M5.9 M2.9 M
Slightly volatile
Research Development22.3 M21.3 M6.8 M
Slightly volatile
Interest Income362.8 K331.2 K127.8 K
Slightly volatile
Reconciled Depreciation101.3 K96.5 K30 K
Slightly volatile

BriaCell Therapeutics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash FlowM10.5 M9.1 M
Slightly volatile
Begin Period Cash Flow819 K862.1 K8.1 M
Slightly volatile
Stock Based Compensation878.1 K776.9 K832.3 K
Slightly volatile
Depreciation112 K106.6 K24.8 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Invested Capital622.1 K673.5 K814.6 K
Slightly volatile
Average Payables749.9 K714.2 K737 K
Slightly volatile
Capex To Depreciation0.00.0196
Slightly volatile
Payables Turnover0.04390.03260.072
Slightly volatile
Cash Per Share40.1142.2257106
Slightly volatile
Days Payables Outstanding10.7 K11.2 K7.4 K
Slightly volatile
Net Current Asset Value357.4 K402 K438.3 K
Slightly volatile
Income Quality1.431.06082.0655
Pretty Stable
Tangible Asset Value628.6 K675.2 K823.5 K
Slightly volatile
Intangibles To Total Assets0.00810.00850.0818
Very volatile
Current Ratio4.765.009214.9626
Pretty Stable
Capex Per Share0.00.074.4028
Slightly volatile
Average ReceivablesM967.4 K227.3 K
Slightly volatile
Interest Debt Per Share0.130.144.8029
Pretty Stable
Debt To Assets5.0E-45.0E-40.3206
Slightly volatile
Days Of Payables Outstanding10.7 K11.2 K7.4 K
Slightly volatile
Ebt Per Ebit0.930.976270.0441
Very volatile
Long Term Debt To Capitalization4.0E-44.0E-44.0E-4
Slightly volatile
Quick Ratio4.765.009214.9008
Pretty Stable
Cash Ratio2.512.63812.1977
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.111.171.6364
Slightly volatile
Debt Ratio5.0E-45.0E-40.3206
Slightly volatile

BriaCell Therapeutics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.1 M4.3 M126 M
Very volatile
Working Capital357.4 K402 K438.3 K
Slightly volatile

BriaCell Fundamental Market Drivers

About BriaCell Therapeutics Financial Statements

BriaCell Therapeutics investors use historical fundamental indicators, such as BriaCell Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BriaCell Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue456.2 K405.5 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BriaCell Stock Analysis

When running BriaCell Therapeutics' price analysis, check to measure BriaCell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BriaCell Therapeutics is operating at the current time. Most of BriaCell Therapeutics' value examination focuses on studying past and present price action to predict the probability of BriaCell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BriaCell Therapeutics' price. Additionally, you may evaluate how the addition of BriaCell Therapeutics to your portfolios can decrease your overall portfolio volatility.